ALLERDIA INC
Last verified 2026-05-16. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.0Mattributed |
|---|---|
| Latest round | grant, $2.0M, 2024-01-01attributed |
| Founded | 2019 |
| Headquarters | LOS ANGELES, California |
| Industry | bio |
| Stage | unknown |
| Website | allerdia.com. |
Allerdia develops rapid immunosensor allergy diagnostics using R-LFIA technology. It serves point-of-care providers running serum or capillary blood tests with 15-minute turnaround. Differentiator: simultaneous detection of 10 allergic IgE types with cross-reactivity filtering.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-01 | grant | $2.0M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.0M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $2.0M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | allerdia.com., read 2026-05-16 |
| Description | self-reported | allerdia.com., read 2026-05-16 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.